Marian Constantin

PureTech Scientific LLC

EMEA Regional Business Manager

Current lectures/posters

16.10.2026

11:15

-

11:30

-

Screening and Validation of Glyclean®D Glycolic Acid–Based Formulations for Broad-Spectrum Bactericidal and Virucidal Efficacy

(available in the SOFW media library after the congress)

Lecture Language: English

The demand for high-performance surface disinfectants with demonstrated efficacy against both bacteria and viruses continues to drive the development of multi-component antimicrobial systems. Glycolic acid, an α-hydroxy acid with intrinsic antimicrobial activity, represents a promising foundation for such formulations, particularly when combined with complementary surfactant systems and auxiliary boosters. Commercial glycolic acid–based technologies such as Glyclean® D from PureTech Scientific offer broad-spectrum antimicrobial efficacy, one-step cleaning and disinfecting capability and improved environmental and user-safety profiles compared with some conventional chemistries. However, systematic evaluation of glycolic acid–based combinations across both bactericidal and virucidal endpoints under harmonized standards remains limited.
In this study, a structured screening and validation approach was employed to assess the antimicrobial performance of a range of glycolic acid–based formulations incorporating diverse surfactant classes and boosters. Candidate formulations inspired by commercial Glyclean® D platforms were screened using EN-standardized suspension tests for bactericidal and virucidal activity (EN 1276 and EN 14476), under defined clean or dirty conditions and against representative bacteria and viruses. Based on predefined performance criteria, a subset of formulations was selected for further evaluation using both suspension and surface-based methodologies, including EN 13697 for bactericidal activity alongside EN 14476 and EN 16777 for virucidal activity.
The screening phase enabled rapid identification of formulation systems exhibiting enhanced antimicrobial performance relative to glycolic acid alone, highlighting synergistic interactions between glycolic acid, surfactants and auxiliary boosters. Subsequent validation demonstrated that selected formulations achieved the required log₁₀ reduction thresholds for both bactericidal and virucidal claims under relevant test conditions.
Overall, this work establishes a robust framework for the development and evaluation of glycolic acid–based surface disinfectants, enabling efficient identification of formulations capable of meeting efficacy standards while maintaining practical application characteristics. The findings further support the applicability of Glyclean® D–type technologies for household, industrial and institutional surface disinfection applications.

16.10.2026

09:30

-

09:45

-

Multifunctional Antimicrobial Contribution of Glycolic Acid in Low-Ph Cosmetic Formulation

(available in the SOFW media library after the congress)

Lecture Language: English

Reducing reliance on conventional preservation systems remains a challenge for the cosmetic industry. One potential strategy is the use of multifunctional ingredients to simplify formulations while maintaining product performance. Organic acids are widely used in personal care for their cosmetic benefits; however, their contribution to microbial control in finished formulations has not been well characterized.
This work evaluates the antimicrobial activity of glycolic acid and its contribution to preservation efficacy in low-pH cosmetic formulations. Model serum formulations containing glycolic acid were prepared at concentrations ranging from 1–8% and adjusted to pH values between 3.5 and 4.2. Antimicrobial effectiveness was assessed using preservative challenge testing against Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, and Aspergillus brasiliensis. Formulations containing glycolic acid demonstrated substantial microbial reductions, including systems containing 1% glycolic acid at pH 3.8.
To further characterize antimicrobial activity, minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC), and minimal fungicidal concentration (MFC) testing were conducted against a broader panel of microorganisms relevant to cosmetic contamination. Glycolic acid inhibited several bacterial species at concentrations as low as 0.25%, with bactericidal activity generally observed between 0.5% and 2.5% depending on the organism.
These results demonstrate that glycolic acid can contribute measurable antimicrobial functionality in finished cosmetic formulations when formulated near its pKa, where the proportion of undissociated acid is maximized. This suggests that glycolic acid can function as a multifunctional formulation component, contributing both cosmetic performance and preservation support in low-pH cosmetic systems.

42 | Screening and Validation of Glycolic Acid-Based Disinfectant Formulations for Broad-Spectrum Bactericidal and Virucidal Efficacy

The demand for high-performance surface disinfectants with demonstrated efficacy against both bacteria and viruses continues to drive the development of optimized multi-component antimicrobial systems. Glycolic acid, an α-hydroxy acid with intrinsic antimicrobial activity, represents a promising foundation for such formulations, particularly when combined with complementary surfactant systems and auxiliary boosters. However, systematic evaluation of glycolic acid–based combinations across both bactericidal and virucidal endpoints under harmonized standards remains limited.
In this study, a structured screening and validation approach was employed to assess the antimicrobial performance of a range of glycolic acid–based formulations incorporating diverse surfactant classes and boosters. An initial panel of candidate formulations was screened using EN-standardized suspension tests for bactericidal and virucidal activity (EN 1276 and EN 14476), under defined clean or dirty conditions and against representative bacteria and viruses. Based on predefined performance criteria, a subset of leading formulations was selected for further evaluation using both suspension and surface-based methodologies, including EN 13697 (for bactericidal activity), alongside EN 14476 and EN 16777 (for virucidal activity).
The screening phase enabled rapid identification of formulation systems exhibiting enhanced antimicrobial performance relative to glycolic acid alone, highlighting the role of complementary mechanisms. Subsequent validation demonstrated that selected formulations achieved the required log₁₀ reduction thresholds for both bactericidal and virucidal claims under relevant test conditions, including simulated organic soiling.
Overall, this work establishes a robust and scalable framework for the development and evaluation of glycolic acid–based surface disinfectants, enabling efficient identification of formulations capable of meeting regulatory efficacy standards while maintaining practical application characteristics.